ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

Morgans Under the Microscope

Morgans Under the Microscope

Por: Morgans Financial Limited

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.

96 episodios disponibles

Latest episodes of the podcast Morgans Under the Microscope

Mostrando página 2 de 5

Under the microscope: Weekly Wrap Week Ending 13 November 2020 16/11/2020

Under the microscope: Weekly Wrap Week Ending 13 November 2020 16/11/2020

Under the microscope: ResApp (ASX:RAP) - Tony Keating, CEO and MD 29/10/2020

Under the microscope: Covid-19 Vaccine - Dr. Derek Jellinek, Senior Analyst 13/10/2020

Under the microscope: Neuren (ASX:NEU) - Jon Pilcher, Chief Executive Officer 01/10/2020

Under the microscope: Volpara (ASX:VHT) - Scott Power, Senior Analyst 24/09/2020

Under the microscope: Weekly Wrap Week Ending 4 September 2020 06/09/2020

Under the microscope: Opyl (ASX:OPL) - Michelle Gallaher, Chief Executive Officer 18/08/2020

Under the microscope: Regeneus (ASX:RGS) - Leo Lee, Chief Executive Officer 18/08/2020

Under the microscope: Reporting Season – August 2020 Update 13/08/2020

Under the microscope: Weekly Wrap Week Ending 31 July 2020 31/07/2020

Under the microscope: Weekly Wrap Week Ending 10 July 2020 13/07/2020

Under the microscope: Mach7 Technologies (ASX:M7T) - Scott Power, Senior Analyst 07/07/2020

Under the microscope: Cochlear (ASX:COH) - Derek Jellinek, Senior Analyst 06/07/2020

Under the microscope: Imagion Biosystems (ASX:IBX) - Robert Proulx, Chief Executive Officer 29/06/2020

Under the microscope: Regeneus (ASX:RGS) - Iain Wilkie, Analyst 25/06/2020

Under the microscope: ResApp Health (ASX:RAP) - Tony Keating, Managing Director & CEO 09/06/2020

Under the microscope: Weekly Wrap Week Ending 5 June 2020 05/06/2020

Under the microscope: Healthcare Update - Scott Power, Senior Analyst 29/05/2020

Under the microscope: Neuren Pharmaceuticals (ASX:NEU) - Jon Pilcher, Chief Executive Officer 29/05/2020

« Primera ‹ Anterior 1 2 3 4 5 Siguiente › Última »